Temozolomide

Product Description

Temozolomide (CAS Number: 85622-93-1)
Temozolomide is an alkylating agent indicated to treat brain tumours. this drug was discovered by The Cancer Research Campaign.It inhibits the cancer cells from making new DNA so that they cannot split into 2 new cancer cells. It is strictly contraindicated in pregnant ladies and breastfeeding mothers since the medication may cause birth defects in newborns. It has been advised to avoid combinations during temozolomide treatment.
Chemical formula: C₆H₆N₆O₂
Synonyms: 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide;CCRG 81045;Temozolodida [Spanish];Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-;Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide,3,4-dihydro-3-methyl-4-oxo-;3-methyl-2-oxo-1,3,4,5,8-pentazabicyclo[4.3.0]nona-4,6,8-triene-7-carboxamide;
Molecular weight:  194.15
Melting Point:  212 °C    
Assay      :  99.7  %
Boiling Point:    526.6 °C at 760 mmHg
Flash Point:   272.3 °C
Appearance: Off-white to light-pink crystalline solid
Package  : 5/10/25 kg / fiber drum